John H. Lawrence
2017
In 2017, John H. Lawrence earned a total compensation of $4.1M as Senior Vice President, Chief Medical Officer at Portola Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $31,533 |
|---|---|
| Option Awards | $3,726,525 |
| Salary | $66,980 |
| Stock Awards | $253,750 |
| Other | $1,000 |
| Total | $4,079,788 |
Lawrence received $3.7M in option awards, accounting for 91% of the total pay in 2017.
Lawrence also received $31.5K in non-equity incentive plan, $67K in salary, $253.8K in stock awards and $1K in other compensation.
Rankings
In 2017, John H. Lawrence's compensation ranked 2,509th out of 14,666 executives tracked by ExecPay. In other words, Lawrence earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,509 out of 14,666 | 83rd |
Division Manufacturing | 874 out of 5,772 | 85th |
Major group Chemicals And Allied Products | 231 out of 2,075 | 89th |
Industry group Drugs | 177 out of 1,731 | 90th |
Industry Pharmaceutical Preparations | 142 out of 1,333 | 89th |
Source: SEC filing on April 24, 2018.
Lawrence's colleagues
We found four more compensation records of executives who worked with John H. Lawrence at Portola Pharmaceuticals in 2017.
2017
William Lis
Portola Pharmaceuticals
Chief Executive Officer
2017
Mardi Dier
Portola Pharmaceuticals
Chief Financial Officer
2017
Tao Fu
Portola Pharmaceuticals
Executive Vice President, Chief Commercial and Business Officer
2017
John Curnutte
Portola Pharmaceuticals